Document is current
Any future updates will be listed below
-
Authors
Borrego, Belén
Alonso, Celia
Moreno, Sandra
Calvo-Pinilla, Eva
Lorenzo, Gema
Sánchez-Cordón, Pedro J.
Brun, Alejandro
-
Funding
Funding for this research was provided by:
Agencia Estatal de Investigación (PdC2021-121717-I00, PdC2021-121717-I00, PdC2021-121717-I00, PdC2021-121717-I00, PdC2021-121717-I00, PdC2021-121717-I00, PdC2021-121717-I00)
European Union (Next Generation EU/PRTR, Next Generation EU/PRTR, Next Generation EU/PRTR, Next Generation EU/PRTR, Next Generation EU/PRTR, Next Generation EU/PRTR, Next Generation EU/PRTR)
- License Information
-
More Information
Article History
Received: 7 February 2025
Accepted: 29 July 2025
First Online: 29 August 2025
Competing interests
: A.B., B.B. and S.M. are the inventors of patent WO/2021/245313 (application PCT/ES2021/070403), which was filed with the Spanish National Research Council (Agencia Estatal Consejo Superior de Investigaciones Científicas, CSIC) and is currently being extended to several third countries. This manuscript supports the safety and efficacy of a vaccine candidate that is the subject of patent protection. All other authors declare no competing interests.
